Talking IPOs and trends in science with NYSE's Eric Dimise
Eric Dimise, Site Lead, Healthcare & Life Sciences Capital Markets at NYSE, shares his thoughts on the optimism reverberating throughout the biotech sector and what it means for capital markets.